Metal transporters in intestine and brain: their involvement in metal-associated neurotoxicities

被引:80
作者
Bressler, Joseph P. [1 ]
Olivi, Luisa
Cheong, Jae Hoon
Kim, Yongbae
Maerten, Alex
Bannon, Desmond
机构
[1] Kennedy Krieger Inst, Dept Neurol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA
[3] Sahmyook Univ, Sch Pharm, Seoul, South Korea
[4] Soonchunhyang Univ, Dept Prevent Med, Chunan, South Korea
[5] USA, Aberdeen Proving Ground, MD 21010 USA
关键词
brain; disease; intestine; metals; transporters;
D O I
10.1177/0960327107070573
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The transport of essential metals and other nutrients across tight membrane barriers such as the gastrointestinal tract and blood-brain barrier is mediated by specific transport mechanisms. Specific transporters take up metals at the apical surface and export them at the basolateral surface, and are involved in their intracellular distribution. Transporters for each of the major essential metals, calcium, iron and zinc, have been identified. These transporters also mediate the transport of non-essential metals across tight membrane barriers. For example, the intestinal iron transporter divalent metal transporter 1 mediates the uptake of lead and cadmium. The levels of essential metals are strictly regulated by transporters. When dietary levels of essential metals are low, levels of the corresponding transporters increase in the intestine, after which there is a greater potential for increased transport of toxic metals. In the brain, the strict regulation of metals prevents injury that potentially would result from oxidative damage induced by the essential metals iron, copper and zinc. Indeed, the oxidative damage found in neurodegenerative diseases is likely to be due to higher levels of these metals. Involvement of intracellular transporters for copper and zinc has been shown in animal models of Alzheimer's disease, raising the possibility that higher levels of iron, zinc and copper might be due to a disruption in the activity of transporters. Accordingly, exposure to toxicants that affect the activity of transporters potentially could contribute to the aetiology/progression of neurodegenerative diseases.
引用
收藏
页码:221 / 229
页数:9
相关论文
共 100 条
  • [1] Chemistry and biology of eukaryotic iron metabolism
    Aisen, P
    Enns, C
    Wessling-Resnick, M
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2001, 33 (10) : 940 - 959
  • [2] AMBUDKAR IS, 1992, MOL CELL BIOCHEM, V114, P73
  • [3] TIGHT JUNCTIONS AND THE MOLECULAR-BASIS FOR REGULATION OF PARACELLULAR PERMEABILITY
    ANDERSON, JM
    VANITALLIE, CM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1995, 269 (04): : G467 - G475
  • [4] DMT1, a physiologically relevant apical Cu1+ transporter of intestinal cells
    Arredondo, M
    Muñoz, P
    Mura, CV
    Núñez, MT
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2003, 284 (06): : C1525 - C1530
  • [5] Neurodegenerative diseases and exposure to pesticides in the elderly
    Baldi, I
    Lebailly, P
    Mohammed-Brahim, B
    Letenneur, L
    Dartigues, JF
    Brochard, P
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 157 (05) : 409 - 414
  • [6] Blood lead concentration and children's anthropometric dimensions in the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994
    Ballew, C
    Khan, LK
    Kaufmann, R
    Mokdad, A
    Miller, DT
    Gunter, EW
    [J]. JOURNAL OF PEDIATRICS, 1999, 134 (05) : 623 - 630
  • [7] Effect of DMT1 knockdown on iron, cadmium, and lead uptake in Caco-2 cells
    Bannon, DI
    Abounader, R
    Lees, PSJ
    Bressler, JP
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2003, 284 (01): : C44 - C50
  • [8] Uptake of lead and iron by divalent metal transporter 1 in yeast and mammalian cells
    Bannon, DI
    Portnoy, ME
    Olivi, L
    Lees, PSJ
    Culotta, VC
    Bressler, JP
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 295 (04) : 978 - 984
  • [9] Neurodegenerative diseases and oxidative stress
    Barnham, KJ
    Masters, CL
    Bush, AI
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (03) : 205 - 214
  • [10] Animal models of Parkinson's disease
    Betarbet, R
    Sherer, TB
    Greenamyre, JT
    [J]. BIOESSAYS, 2002, 24 (04) : 308 - 318